Just – Evotec Biologics' J.POD® wins CPhI Pharma Award 2022 for Manufacturing Technology and Equipment

  • Evotec SE today announced that the Company’s Seattle-based subsidiary, Just – Evotec Biologics, Inc. has been selected as a winner of a CPhI Pharma Award 2022. Just – Evotec Biologics entered the competition in the category “Manufacturing Technology and Equipment” with its flexible cGMP biomanufacturing plant J.POD®. J.POD® represents a paradigm shift in biologics manufacturing.  Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/just—evotec-biologics-jpodr-wins-cphi-pharma-award-2022-for-manufacturing-technology-and-equipment-6228

    Du magst vielleicht auch